5-[I-125/123]Iodo-3(2(S)-azetidinylmethoxy)pyridine, a radioiodinated analog of A-85380 for in vivo studies of central nicotinic acetylcholine receptors

Life Sciences

Volumn 62, Issue 22, 1998, Pages

  Musachio, John L ^a   Scheffel, Ursula ^a   Finley, Paige A ^a   Zhan, Yougen ^a   Mochizuki, Takao ^a   Wagner Jr , Henry N ^a   Dannals, Robert F ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

I 123; I 125; Nicotinic acetylcholine receptor; Single photon emission computed tomography

Indexed keywords

2 FLUORO 3 (AZETIDINYLMETHOXY)PYRIDINE F 18; CYTISINE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR; SCOPOLAMINE; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN CORTEX; BRAIN REGION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; RECEPTOR BINDING; RECEPTOR DENSITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBCUTANEOUS DRUG ADMINISTRATION; THALAMUS;

ANIMALIA;

EID: 0032562411     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00180-5     Document Type: Article

References (20)

1. 1. J. LINDSTROM, R. ANAND, X. PENG, V. GERZANICH, F. WANG and Y. LI, Ann. N.Y. Acad. Sci. 757 100-116 (1995).
2. 2. W.A. CORRIGALL, K.B.J. FRANKLIN, K.M. COEN and P.B.S. Clarke, Psychopharmacol. 107 285-289 (1992).
3. 3. D.J.K. BALFOUR and K.O. FAGERSTRÖM, Pharmacol. Ther. 72 51-81 (1996).
4. 4. P.J. WHITEHOUSE, A.M. MARTINO, P.O. ANTUONO, P.R. LOWENSTEIN, J.T. COYLE, D.L. PRICE and K.J. KELLAR, Brain Res. 371 146-151 (1986).
5. 5. A. NORDBERG and G. WINBLAD (1986) Neurosci. Lett. 72 115-119 (1986).
6. 6. E.D. LONDON, M.J. BALL and S.B. WALLER (1989) Neurochem. Res. 14 745-750 (1989).
7. 7. P.M. LIPPIELO, Alzheimer's Disease: Therapeutic Strategies, E. Giacobini, and R. Becker (Eds), 186-190, Birkhauser, Boston (1994).
8. 8. J.D. BRIONI, M.W. DECKER, J.P. SULLIVAN and S.P. ARNERIC, Adv. Pharmacol. 37 153-214 (1997).
9. 9. H. NYBÄCK, C. HALLIDIN, A. ÅHLIN, M. CURVALL and L. ERIKSSON, Psychopharmacol. 115 31-36 (1994).
10. 10. Y.S. DING, S.J. GATLEY, J.S. FOWLER, N.D. VOLKOW, D. AGGARWAL, J. LOGAN, S.L. DEWEY, F.I. CARROLL and M.J. KUHAR, Synapse 24 403-407 (1996).
11. 11. J.L. MUSACHIO, V.L. VILLEMAGNE, U. SCHEFFEL, M. STATHIS, P. FINLEY, A. HORTI, E.D. LONDON and R.F. DANNALS, Synapse 26 392-399 (1997).
12. 12. V.L. VILLEMAGNE, A. HORTI, U. SCHEFFEL, H.T. RAVERT, P. FINLEY, D.J. CLOUGH, E.D. LONDON, H.N. WAGNER JR. and R.F. DANNALS, J. Nucl. Med. 38 1737-1741 (1997).
13. 13. P. MOLINA, Y.S. DING, F.I. CARROLL, F. LIANG, N. VOLKOW, M. KUHAR, N. PAPPAS, P. KING, N. ABUMRAD and J.S. FOWLER, J. Nucl. Med. 38S 287P (abs) (1997).
14. 14. M.A. ABREO, N.-H. LIN, D.S. GARVEY, D.E. GUNN, A.-M. HETTINGER, J.T. WASICAK, P.A. PAVLIK, Y.C. MARTIN, D.L. DONNELLY-ROBERTS, D.J. ANDERSON, J.P. SULLIVAN, M. WILLIAMS, S.P. ARNERIC and M.W. HOLLADAY, J. Med. Chem. 39 817-825 (1996).
15. 15. A.G. HORTI, A.O. KOREN, U. SCHEFFEL, A.S. KIMES, H.T. RAVERT, J.L. MUSACHIO, P.A. FINLEY, Y. ZHAN, R.F. DANNALS and E.D. LONDON, Soc. Neurosci. Abst. 23 382 (1997).
16. 16. M. KASSIOU, U.A. SCHEFFEL, H.T. RAVERT, W.B. MATHEWS, J.L. MUSACHIO, E.D. LONDON and R.F. DANNALS, Life Sci. (in press).
17. 17. M.I. DÁVILA-GARCÍA, J.L. MUSACHIO, D.C. PERRY, Y. XIAO, A. HORTI, E.D. LONDON, R.F. DANNALS and K.J. KELLAR, J. Pharmacol. Exp. Ther. 282 445-451 (1997).
18. 18. H. SAJI, A. WATANABE, Y. MAGATA, Y. OHMOMO, Y. KIYONO, Y. YAMADA, Y. OODA, Y. YONEKURA, J. KONISHI and A. YOKOYAMA, Chem. Pharm. Bull. 45 284-290 (1997).
19. 19. J.P. SULLIVAN, M.W. DECKER, J.D. BRIONI, D. DONNELLY-ROBERTS, D.J. ANDERSON, A.W. BANNON, C.-H. KANG, P. ADAMS, M. PIATTONI-KAPLAN, M.J. BUCKLEY, M. GOPALAKRISHNAN, M. WILLIAMS and S.P. ARNERIC, Neuropharmacol. 35 725-734 (1996).
20. 20. D.E. KUHL, R.A. KOEPPE, J.A. FESSLER, S. MINOSHIMA, R.J. ACKERMANN, J.E. CAREY, D.L. GILDERSLEEVE, K.A. FREY and D.M. WIELAND, J. Nucl. Med. 35 405-410 (1994).